Write a reviewFor vendors
♡
Home / Investors / Annalisa D'Andrea

Annalisa D'Andrea

Venture Fund · Boston

About Annalisa D'Andrea

Venture capital investor (Chief Scientific Officer) based in Boston, Massachusetts. Focus areas include Health Care, Autoimmune Diseases, Wellness. Invests at seed stage. Past investments include Protai, Spero Therapeutics, Engimmune Therapeutics.

Investment focus

Stages
Seed
Sectors
Health CareAutoimmune DiseasesWellnessImmunotherapyEngineeringBiotechnologyClinical TrialsResearchMedicalB2BTherapeuticsMedia and EntertainmentPharmaceuticalsOncology

Portfolio

No portfolio companies recorded yet; Annalisa D'Andrea reports 4 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Abbie Celniker

Venture Fund · Newton
SeedHealth CareDrug DiscoveryAutoimmune DiseasesWellness+16
60Investments
—Exits

Abhinaya Konduru

Venture Fund · Chicago
SeedPre-SeedEarly Stage VentureHealth CareE-commercePaymentsCybersecurity+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam Rothenberg

Angel Investor · New York City
SeedPre-SeedEarly Stage VentureSeries AHealth CareE-commerceMessagingDisruptive Innovation+16
60Investments
—Exits